<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Lara | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/visionrefund64/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/visionrefund64/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lara.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">f0cf15d4bb2aecec1770d924fd877842</guid>
				<title>Lara posted an update: Causes of revision surgery in L5 group were distal [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42441/</link>
				<pubDate>Sun, 09 Feb 2025 09:25:38 -0800</pubDate>

									<content:encoded><![CDATA[<p>Causes of revision surgery in L5 group were distal junctional failure in 5 patients and foraminal stenosis at L5-S1 in 1. All of them underwent additional spinal fusion to the sacrum. Whereas, causes of revision surgery in S1 group were rod fracture in 2 patients and proximal junctional failure in 1. <a href="https://www.selleckchem.com/products/20-hydroxyecdysone.html" rel="nofollow ugc">20-Hydroxyecdysone solubility dmso</a> Conclusion&hellip;<span class="activity-read-more" id="activity-read-more-42441"><a href="http://www.nationalboardinstitute.com/activity/p/42441/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7b2e86a30af12b7df773c2641317e072</guid>
				<title>Lara posted an update: In the diuretic and nitrate groups, logBNP post-intervention [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40815/</link>
				<pubDate>Fri, 07 Feb 2025 09:26:49 -0800</pubDate>

									<content:encoded><![CDATA[<p>In the diuretic and nitrate groups, logBNP post-intervention was significantly lower than pre-intervention, but not in the lifestyle modification group. CONCLUSIONS Compared with lifestyle modifications, diuretic and nitrate therapy for 1 week may be more effective management of HF detected by decreased ITI. However, lifestyle modification may&hellip;<span class="activity-read-more" id="activity-read-more-40815"><a href="http://www.nationalboardinstitute.com/activity/p/40815/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6ee30ffb3ddd35ae5839f868393a20bb</guid>
				<title>Lara posted an update: Most patients exhibited no signs of recurrence during the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38930/</link>
				<pubDate>Wed, 05 Feb 2025 09:20:43 -0800</pubDate>

									<content:encoded><![CDATA[<p>Most patients exhibited no signs of recurrence during the follow-up period. Conclusions Direct use of ALA-PDT or after panhysterectomy did not necessarily lead to a negative result; however, ALA-PDT after LEEP or panhysterectomy combined with LEEP yielded a satisfactory curative effect on VAIN. Although recurrence rates need to be monitored in&hellip;<span class="activity-read-more" id="activity-read-more-38930"><a href="http://www.nationalboardinstitute.com/activity/p/38930/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f2ec26ec8ced72164542623772686b42</guid>
				<title>Lara posted an update: Improvement in the NMSS and PDQ-39 summary index were [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38091/</link>
				<pubDate>Tue, 04 Feb 2025 09:21:44 -0800</pubDate>

									<content:encoded><![CDATA[<p>Improvement in the NMSS and PDQ-39 summary index were observed in the PRM but not in the placebo group; UPDRS-III score was not significantly changed in either group. PSQI improvement correlated with improvement in NMSS score and PDQ-39 summary index. Regarding safety, all enrolled subjects did not complain of side effects due to PRM. Conclusion&hellip;<span class="activity-read-more" id="activity-read-more-38091"><a href="http://www.nationalboardinstitute.com/activity/p/38091/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c3726dd93074e56739b956579dbe0518</guid>
				<title>Lara posted an update: sensitivity was 87.0%. Presepsin has been shown to have an [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36277/</link>
				<pubDate>Sun, 02 Feb 2025 09:26:37 -0800</pubDate>

									<content:encoded><![CDATA[<p>sensitivity was 87.0%. Presepsin has been shown to have an optimal threshold of 1,025.00 pg/mL for the diagnosis of sepsis, the specificity was 83.0% and the sensitivity was 85.0%. The sTREM-1 and presepsin plasma levels have great reference value for the diagnosis of sepsis, and the sTREM-1 and presepsin plasma levels are relative to the severity&hellip;<span class="activity-read-more" id="activity-read-more-36277"><a href="http://www.nationalboardinstitute.com/activity/p/36277/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6b8de7940326d77ae14d945920e9b0be</guid>
				<title>Lara posted an update: Stabilization of protein-protein interactions (PPIs) holds [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34475/</link>
				<pubDate>Fri, 31 Jan 2025 09:05:23 -0800</pubDate>

									<content:encoded><![CDATA[<p>Stabilization of protein-protein interactions (PPIs) holds great potential for therapeutic agents, as illustrated by the successful drugs rapamycin and lenalidomide. However, how such interface-binding molecules can be created in a rational, bottom-up manner is a largely unanswered question. We report here how a fragment-based approach can be used&hellip;<span class="activity-read-more" id="activity-read-more-34475"><a href="http://www.nationalboardinstitute.com/activity/p/34475/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7d6107da754188ae53135d8015fd62e2</guid>
				<title>Lara posted an update: Aims To compare intravitreal ranibizumab as monotherapy or [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33447/</link>
				<pubDate>Thu, 30 Jan 2025 09:22:27 -0800</pubDate>

									<content:encoded><![CDATA[<p>Aims To compare intravitreal ranibizumab as monotherapy or in combination with panretinal photocoagulation (PRP) in patients with proliferative diabetic retinopathy (PDR) and coexistent diabetic macular edema (DME) in a long-term follow-up of 24 months. Methods Participants in this prospective study were 47 patients with PDR and concurrent DME,&hellip;<span class="activity-read-more" id="activity-read-more-33447"><a href="http://www.nationalboardinstitute.com/activity/p/33447/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9dfa4aca5febe7f27aef57e66f407d57</guid>
				<title>Lara posted an update: OBJECTIVES AND DESIGN Data from the Italian national [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27234/</link>
				<pubDate>Tue, 28 Jan 2025 08:53:45 -0800</pubDate>

									<content:encoded><![CDATA[<p>OBJECTIVES AND DESIGN Data from the Italian national point-prevalence survey (PPS) of healthcare-associated infections (HAIs) were used to evaluate antimicrobial usage (AMU) in Italy and to identify targets for future interventions. METHODS The second Italian PPS was conducted in 2016 as part of the European PPS initiated by the ECDC. We compared&hellip;<span class="activity-read-more" id="activity-read-more-27234"><a href="http://www.nationalboardinstitute.com/activity/p/27234/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8109398ce7548a708b24350fa6077990</guid>
				<title>Lara became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27136/</link>
				<pubDate>Tue, 28 Jan 2025 08:48:31 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>